LITB:NYSELightInTheBox Holding Co., Ltd. Analysis
Data as of 2026-06-12 - not real-time
$3.60
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
LightInTheBox (LITB) is trading at $3.595, comfortably above its 20‑day SMA of 3.12 and its 50‑day SMA of 2.63, confirming a bullish price trend. The RSI sits at 68.8, just shy of overbought territory, while the MACD line (0.33) remains above its signal (0.30), adding momentum support. Fundamentals show a solid 10.5% revenue growth YoY, a robust 65% gross margin and a recent Q1 record profit of $1.2 M, driven by an 81% surge in branded apparel sales. Valuation metrics are strikingly low – a trailing P/E of 5.99, forward P/E of 3.99 and a price‑to‑sales of 0.29 – suggesting the stock may be undervalued despite a negative book value. However, the company reports zero operating cash flow, a negative equity base (PB = ‑23) and a historical max drawdown of ‑55%, while volatility is elevated at 77% over the past 30 days.
The market sentiment is extremely bullish (Fear‑Greed Index 88.18), but liquidity is thin (average volume ~11k vs today’s 6.1k) and beta is modest at 0.77, indicating limited systematic risk. Together, the technical upside, improving earnings narrative, and deep valuation discounts support a cautious buying case, tempered by cash‑flow weakness and high price volatility.
The market sentiment is extremely bullish (Fear‑Greed Index 88.18), but liquidity is thin (average volume ~11k vs today’s 6.1k) and beta is modest at 0.77, indicating limited systematic risk. Together, the technical upside, improving earnings narrative, and deep valuation discounts support a cautious buying case, tempered by cash‑flow weakness and high price volatility.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical setup (price above SMA20/50, bullish MACD)
- Recent record profit and double‑digit revenue growth
- Low valuation multiples (P/E ~6, P/S ~0.29)
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained apparel segment expansion (+81% YoY)
- Continued margin stability (gross margin ~65%)
- Undervalued price relative to earnings and sales
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Negative equity and zero operating cash flow raise solvency concerns
- High price volatility (≈78% 30‑day) and thin trading volume
- Potential for further upside if cash‑flow generation improves
Key Metrics & Analysis
Financial Health
Revenue Growth10.50%
Profit Margin4.07%
P/E Ratio6.0
ROA9.46%
P/B Ratio-23.2
Technical Analysis
TrendBullish
RSI68.8
Support$2.36
Resistance$3.89
MA 20$3.12
MA 50$2.63
MA 200$2.42
MACDBullish
VolumeDecreasing
Fear & Greed Index88.18
Valuation
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.77
Volatility77.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.